On Wednesday, Vincerx Pharma Inc (VINC) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.09 or -5.45% from the prior close of $1.65. The stock opened at $1.97 and ...

In terms of valuation, Vincerx Pharma Inc’s market capitalization stands at $3.62 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

In a turbulent market environment, VINC stock has reached its 52-week low, trading at $1.62, with technical indicators from InvestingPro showing the stock in oversold territory. This price level ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...

Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025SAN MATEO, Calif., Jan. 23, 2025 (GLOBE ...

After a brutal crash, Vincent Kriechmayr, currently the only podium skier in the ÖSV men's speed team, could be out ...

Daniel Hemetsberger narrowly missed out on the downhill podium in fourth place at the Hahnenkamm race in Kitzbühel. However, ...

EST Vincerx Pharma (VINC) files $100M mixed securities shelfInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover ...

Vincerx Pharma (VINC) announced that its board of directors approved a 1-for-20 reverse stock split of its issued shares of common stock, which ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

The proud Western New York municipality of Buffalo is in the midst of a unique interval of sporting success, built largely ...